5th Annual Bear Discoveries Research Symposium

Bear Necessities Pediatric Cancer Foundation
Last Modified: October 8, 2010

Share article

Dates: November 19, 2010
Location: Chicago, IL

Sponsoring Group: Bear Necessities Pediatric Cancer Foundation

Web Page URL: www.bearnecessities.org/Symposium/Index.html

Topics Covered: Pediatric Hematology/Oncology Research

Objectives: Distinguish between differences in clinical approaches as they apply to cancer research. Identify new research techniques or information that participants can apply to his or her own research investigations. Address gaps in current knowledge of cancer research.

Agenda: See agenda and CME info here

Fees: $0

Continuing Education: Yes

Adding the drug to paclitaxel/carboplatin may improve survival in non-small-cell lung cancer

Dec 16, 2010 - The addition of ipilimumab to paclitaxel/carboplatin appears to result in superior progression-free survival in patients with stage IIIb/IV non-small-cell lung cancer compared with paclitaxel/carboplatin alone, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology, held from Dec. 9 to 11.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More